Agomab Therapeutics NV

AGMB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.6B · 62 employees
2
SEC Filings
$11.5
Close 2026-05-22
62
Employees

Latest Stock Quote

AGMB 2026-05-22 $11.5 O:$11.05 H:$11.55 L:$10.98 Vol:0.0M VWAP:$11.3007
origin leaf: c432bbfbe51e910ef6465116dca5614cb9c147914f3736525d17d96d9da07a75

2 total filings indexed. 2 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002020932
TickerAGMB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedC9
Websitehttps://www.agomab.com
Listed2026-02-06

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ee8cc5015936a3aaf9b2c33895b5b7447a996fe5eeaae29a6305dfc0c712090c
parent: a4c3d43a2acf48415f43bcda789b367e83be6656227338d12182ddc829cce9f9
content hash: e50940ad7b8c75bf7dc98072699d7cf36c2b660e823bed9c7cde1af6396501c1
signed: 2026-06-02T19:00:06.721Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf